Cargando…
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457191/ https://www.ncbi.nlm.nih.gov/pubmed/37460673 http://dx.doi.org/10.1038/s41375-023-01938-5 |
| _version_ | 1785096868836933632 |
|---|---|
| author | Cesaro, Simone Mikulska, Malgorzata Hirsch, Hans H. Styczynski, Jan Meylan, Sylvain Cordonnier, Catherine Navarro, Davide von Lilienfeld-Toal, Marie Mehra, Varun Marchesi, Francesco Besson, Caroline Masculano, Raul Cordoba Beutel, Gernot Einsele, Herman Maertens, Johan de la Camara, Rafael Ljungman, Per Pagano, Livio |
| author_facet | Cesaro, Simone Mikulska, Malgorzata Hirsch, Hans H. Styczynski, Jan Meylan, Sylvain Cordonnier, Catherine Navarro, Davide von Lilienfeld-Toal, Marie Mehra, Varun Marchesi, Francesco Besson, Caroline Masculano, Raul Cordoba Beutel, Gernot Einsele, Herman Maertens, Johan de la Camara, Rafael Ljungman, Per Pagano, Livio |
| author_sort | Cesaro, Simone |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10457191 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104571912023-08-27 Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9) Cesaro, Simone Mikulska, Malgorzata Hirsch, Hans H. Styczynski, Jan Meylan, Sylvain Cordonnier, Catherine Navarro, Davide von Lilienfeld-Toal, Marie Mehra, Varun Marchesi, Francesco Besson, Caroline Masculano, Raul Cordoba Beutel, Gernot Einsele, Herman Maertens, Johan de la Camara, Rafael Ljungman, Per Pagano, Livio Leukemia Correspondence Nature Publishing Group UK 2023-07-17 2023 /pmc/articles/PMC10457191/ /pubmed/37460673 http://dx.doi.org/10.1038/s41375-023-01938-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Cesaro, Simone Mikulska, Malgorzata Hirsch, Hans H. Styczynski, Jan Meylan, Sylvain Cordonnier, Catherine Navarro, Davide von Lilienfeld-Toal, Marie Mehra, Varun Marchesi, Francesco Besson, Caroline Masculano, Raul Cordoba Beutel, Gernot Einsele, Herman Maertens, Johan de la Camara, Rafael Ljungman, Per Pagano, Livio Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9) |
| title | Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9) |
| title_full | Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9) |
| title_fullStr | Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9) |
| title_full_unstemmed | Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9) |
| title_short | Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9) |
| title_sort | update of recommendations for the management of covid-19 in patients with haematological malignancies, haematopoietic cell transplantation and car t therapy, from the 2022 european conference on infections in leukaemia (ecil 9) |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457191/ https://www.ncbi.nlm.nih.gov/pubmed/37460673 http://dx.doi.org/10.1038/s41375-023-01938-5 |
| work_keys_str_mv | AT cesarosimone updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT mikulskamalgorzata updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT hirschhansh updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT styczynskijan updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT meylansylvain updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT cordonniercatherine updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT navarrodavide updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT vonlilienfeldtoalmarie updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT mehravarun updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT marchesifrancesco updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT bessoncaroline updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT masculanoraulcordoba updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT beutelgernot updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT einseleherman updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT maertensjohan updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT delacamararafael updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT ljungmanper updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 AT paganolivio updateofrecommendationsforthemanagementofcovid19inpatientswithhaematologicalmalignancieshaematopoieticcelltransplantationandcarttherapyfromthe2022europeanconferenceoninfectionsinleukaemiaecil9 |